OctoPlus expands Dutch manufacturing facilities
This article was originally published in Scrip
Executive Summary
The Dutch drug delivery and manufacturing company, OctoPlus, has opened a new GMP facility at its headquarters in Leiden. Its manufacturing capacity has doubled with the new plant, and the firm can now produce clinical trial and small-scale commercial supplies of injectable pharmaceuticals.